Next stop Biogen: Carl Icahn's fight for seats on the board of Biogen Idec (BIIB) comes to a vote Wednesday, June 3. He owns 5.6% of the biotech group. Proxy advisory service RiskMetrics Group is backing two of Icahn's nominees. Icahn gained a seat on Amylin's (AMLN) board this week and is lobbying to ouster top management at Enzon (OTC:ENZN).
Next stop Biogen: Carl Icahn's fight for seats on the board of Biogen Idec (BIIB) comes to a...
Recommended For You
About BMY Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| BMY | - | - |
| Bristol-Myers Squibb Company | ||